Biogen Idec

Latest Biogen Idec News

  1. Avoiding big stock losses requires investor discipline

    Wed, 22 Feb 2012

    including: Cabot Oil & Gas cog : 101%, El Paso ep : 93%, Intuitive Surgical isrg : 80%, Mastercard ma : 66% and Biogen Idec biib : 64%. That means your odds of picking a stock in 2011 that would have undone your bad luck in 2010 would be just

  2. Icahn Boosts Offer for Clorox to $80 Per Share

    Wed, 20 Jul 2011

    struggling companies, with mixed success. His other holdings at the end of the first quarter included the drug maker Biogen Idec Inc ., movie studio Lions Gate Entertainment Corp., Motorola Solutions Inc. and power producer Dynegy Inc., according

  3. Icahn Makes Offer for Clorox

    Fri, 15 Jul 2011

    struggling companies, with mixed success. His other holdings at the end of the first quarter included the drug maker Biogen Idec Inc ., movie studio Lions Gate Entertainment Corp., Motorola Solutions Inc. and power producer Dynegy Inc., according

  4. Icahn Nominates 4 Candidates to Forest Labs Board

    Mon, 13 Jun 2011

    new depression drug Viibryd. Icahn owns stock in a variety of drug companies, including Biogen Idec Inc . Denner and Mulligan joined the board of Biogen Idec in 2009 after a proxy fight, and a third Icahn-backed nominee was added to the board

  5. Wall Street Risks Push Investors Toward Faith-Based Funds

    Thu, 24 Jun 2010

    4.8 percent (the fund has only been operating since December 2009.) Top Holdings: US Bancorp, M&T Bank, Biogen Idec Investing Criteria: The firm offers funds that reflect five Christian denominations: Baptist, Catholic, Christian

  6. Type 1 Diabetes May Have a New Foe

    Wed, 25 Nov 2009

    Health, the Juvenile Diabetes Research Foundation International and the American Diabetes Association. Genentech and Biogen Idec , which make rituximab, provided the medication for the trial. More information There's more on type 1 diabetes

News

  1. Promising Results for Experimental Lymphoma Vaccine

    Sun, 31 May 2009

    each kind of lymphoma," he said. The study was supported by Biovest International. The researchers reported financial links with Accentia Biopharmaceuticals, Biovest International, Antigenics, Biogen Idec , Genentech and Xeme Biopharma.

  2. CT Lung Cancer Screening Leaves a Trail of False Positives

    Sat, 30 May 2009

    Institute. Croswell did not report any conflicts. Bach has reported financial links with Genentech, Wyeth, Abraxis, Biogen - Idec , and Johnson and Johnson. Edelman has reported financial links with Bristol-Myers Squibb, Cyclacel, Eli Lilly

  3. Leukemia Risk From MS Drug May Be Up

    Thu, 30 Apr 2009

    of MS disability, whereas the scores for the interferon-only group decreased slightly. The study was funded by Biogen - Idec , which makes Avonex. More information The National Multiple Sclerosis Society has more on MS . SOURCES: Vittorio

  4. Drug Combo May Relieve MS Symptoms

    Thu, 30 Apr 2009

    improvement on a test of MS disability, while those in the placebo/interferon group showed a slight decline. The Biogen Idec -supported study also found that MS-related brain lesions stayed the same size or shrank in the steroid/interferon

  5. Tysabri May Treat Myelin Sheath Damage From MS

    Tue, 28 Apr 2009

    regenerate and stabilize damage done to the myelin sheath in people with multiple sclerosis (MS), a study from drug makers Biogen Idec and Elan Corp shows. MS is nervous system disease that affects the brain and spinal cord. Symptoms experienced by

  6. Look for a list of industry leaders in 10-K reports

    Mon, 6 Apr 2009

    also emerge as competitors. These include Genzyme, Amgen, Cephalon, Shire Pharmaceuticals, BioMarin, Celgene, Biogen Idec , and Titan Pharmaceuticals/Schering AG. Finally, we also expect to compete with smaller biotechnology companies

  7. Health Highlights: Oct. 19, 2008

    Sun, 19 Oct 2008

    The drug was obtained through the Mayo Clinic, which consulted with the U.S. Food and Drug Administration. Biogen Idec Inc , which makes Tysabri, didn't approve Baron's use of the drug because the regulatory risks of giving him special

More »
Comments
�???????�??????�?????�????�???�??�?� 

Related Connections

ABC News on FaceBook

follow us

Social Tools Facebook Twitter Twitter RSS Mobile